Cell Line : K2[HUMANMELANOMA]

Cellosaurus Index : CVCL_AT85
Cellosaurus ID : K2[HUMANMELANOMA]

GDSC1 Name , GDSC2 Name : K2
CCLE Name : K2_SKIN

Cancer Type : skin
Dataset : All

Drug Response Information

Click to show/hide information cards below or download all drug response information.

           

Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.

:

Experimental information

Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.

Cellosaurus ID Drug Name Original Dataset(s) Min Dose Max Dose Dose-response
K2[HUMANMELANOMA] (5Z)-7-Oxozeaenol GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] 5-Fluorouracil GDSC1,GDSC2 0.0200 32.0000
K2[HUMANMELANOMA] 965-D2 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] 993-D2 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] ABT737 GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Afatinib GDSC1,GDSC2 0.0020 10.0000
K2[HUMANMELANOMA] Afuresertib GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] AGI-5198 GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] AGI-6780 GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] AGK-2 GDSC2 0.0040 4.0000
K2[HUMANMELANOMA] AICA Ribonucleotide GDSC1 7.8125 2000.0000
K2[HUMANMELANOMA] AKT inhibitor VIII GDSC1 0.0100 10.2400
K2[HUMANMELANOMA] Alectinib GDSC1 0.0200 5.1200
K2[HUMANMELANOMA] Alisertib GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Alpelisib GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] AMG-319 GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Amuvatinib GDSC1 0.0781 20.0000
K2[HUMANMELANOMA] AR-42 GDSC1 0.0200 5.1200
K2[HUMANMELANOMA] AS601245 GDSC1 0.0312 8.0000
K2[HUMANMELANOMA] AS605240 GDSC1 0.0781 20.0000
K2[HUMANMELANOMA] AT-7519 GDSC1 0.0400 10.2400
K2[HUMANMELANOMA] AT13148 GDSC2 0.0080 8.0000
K2[HUMANMELANOMA] Avagacestat GDSC1,GDSC2 0.0100 10.2400
K2[HUMANMELANOMA] Axitinib GDSC1,GDSC2 0.0078 10.0000
K2[HUMANMELANOMA] AZ20 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] AZ6102 GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] AZ960 GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] AZD1208 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] AZD1332 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] AZD1480 GDSC1 0.0098 2.5000
K2[HUMANMELANOMA] AZD2014 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] AZD3514 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] AZD3759 GDSC2 0.0010 1.0000
K2[HUMANMELANOMA] AZD4547 GDSC1,GDSC2 0.0039 10.0000
K2[HUMANMELANOMA] AZD4877 GDSC1 0.0002 0.0390
K2[HUMANMELANOMA] AZD5363 GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] AZD5438 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] AZD5582 GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] AZD6094 GDSC1 0.0098 2.5000
K2[HUMANMELANOMA] AZD6482 GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] AZD6738 GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] AZD7762 GDSC1,GDSC2 0.0010 10.0000
K2[HUMANMELANOMA] AZD7969 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] AZD8055 GDSC1 0.0078 2.0000
K2[HUMANMELANOMA] AZD8186 GDSC1,GDSC2 0.0098 10.0000
K2[HUMANMELANOMA] AZD8835 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] AZD8931 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] BAY ACCi GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] BAY AKT1 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] BAY-61-3606 GDSC1 0.0312 8.0000
K2[HUMANMELANOMA] BAY-HDAC11_1 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] BAY-HDAC11_2 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] BAY-HDAC11_4 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] BAY-MPS-combo 2 (paclitaxel 1 uM) GDSC1 0.0039 1.0000
K2[HUMANMELANOMA] BAY-MPS-combo-1 (paclitaxel 5 uM) GDSC1 0.0039 1.0000
K2[HUMANMELANOMA] BAY-MPS1 GDSC1 0.0117 3.0000
K2[HUMANMELANOMA] Belinostat GDSC1 0.0781 20.0000
K2[HUMANMELANOMA] Bexarotene GDSC1 0.0312 8.0000
K2[HUMANMELANOMA] BI-2536 GDSC2 0.0005 0.5000
K2[HUMANMELANOMA] BIBR-1532 GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Bicalutamide GDSC1,GDSC2 0.0040 10.0000
K2[HUMANMELANOMA] BIX02189 GDSC1 0.0781 20.0000
K2[HUMANMELANOMA] Bleomycin GDSC1 0.2500 64.0000
K2[HUMANMELANOMA] Bleomycin (10 uM) GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] Bleomycin (50 uM) GDSC1 0.1953 50.0000
K2[HUMANMELANOMA] BMS-345541 GDSC1,GDSC2 0.0100 16.0000
K2[HUMANMELANOMA] BMS-536924 GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] BMS-754807 GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Bortezomib GDSC2 0.0000 0.0200
K2[HUMANMELANOMA] Bosutinib GDSC1,GDSC2 0.0020 2.0000
K2[HUMANMELANOMA] BPTES GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] Bryostatin 1 GDSC1 0.0000 0.0080
K2[HUMANMELANOMA] Buparlisib GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] BX-912 GDSC1 0.0400 10.2400
K2[HUMANMELANOMA] BX795 GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Cabozantinib GDSC1 0.0200 5.1200
K2[HUMANMELANOMA] Camptothecin GDSC2 0.0001 0.1000
K2[HUMANMELANOMA] Capivasertib GDSC1 0.1172 30.0000
K2[HUMANMELANOMA] CAY10603 GDSC1 0.0781 20.0000
K2[HUMANMELANOMA] CCT-018159 GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] CCT007093 GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] CCT245232 GDSC1 0.0008 0.2000
K2[HUMANMELANOMA] CCT245467 GDSC1 0.0008 0.2000
K2[HUMANMELANOMA] Cediranib GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Cetuximab GDSC1 0.2570 65.8000
K2[HUMANMELANOMA] CHIR-99021 GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] CI-1040 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] Cisplatin GDSC1 0.0117 10.0000
K2[HUMANMELANOMA] CP466722 GDSC1 0.0625 16.0000
K2[HUMANMELANOMA] CP724714 GDSC1 0.0400 10.2400
K2[HUMANMELANOMA] Crizotinib GDSC2 0.0040 8.0000
K2[HUMANMELANOMA] CRT0105446 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] CRT0105950 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] CRT0160829 GDSC1 0.0781 20.0000
K2[HUMANMELANOMA] CUDC-101 GDSC1 0.0200 5.1200
K2[HUMANMELANOMA] CX-5461 GDSC1 0.0400 10.2400
K2[HUMANMELANOMA] Cyclophosphamide GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Cytarabine GDSC1 0.0078 2.0000
K2[HUMANMELANOMA] CZC24832 GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Dabrafenib GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Dacinostat GDSC1 0.0040 1.0240
K2[HUMANMELANOMA] Dactinomycin GDSC2 0.0008 0.8000
K2[HUMANMELANOMA] Dactolisib GDSC1,GDSC2 0.0003 0.2500
K2[HUMANMELANOMA] Daporinad GDSC1,GDSC2 0.0010 1.0000
K2[HUMANMELANOMA] Dasatinib GDSC2 0.0020 2.0000
K2[HUMANMELANOMA] Dinaciclib GDSC2 0.0010 1.0000
K2[HUMANMELANOMA] DMOG GDSC1 15.6250 4000.0000
K2[HUMANMELANOMA] Docetaxel GDSC1,GDSC2 0.0000 0.0125
K2[HUMANMELANOMA] Doramapimod GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Doxorubicin GDSC1 0.0040 5.0000
K2[HUMANMELANOMA] Dyrk1b_0191 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] EHT-1864 GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Elesclomol GDSC1,GDSC2 0.0002 0.2000
K2[HUMANMELANOMA] Embelin GDSC1 0.1250 32.0000
K2[HUMANMELANOMA] Entinostat GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Entospletinib GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Enzastaurin GDSC1 0.0781 20.0000
K2[HUMANMELANOMA] EphB4_9721 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] Epirubicin GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Epothilone B GDSC1 0.0001 0.0320
K2[HUMANMELANOMA] EPZ004777 GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] EPZ5676 GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Erlotinib GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Etoposide GDSC1 0.0625 16.0000
K2[HUMANMELANOMA] Fedratinib GDSC1 0.0400 10.2400
K2[HUMANMELANOMA] FEN1_3940 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] FGFR_0939 GDSC1 0.0098 2.5000
K2[HUMANMELANOMA] FGFR_3831 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] FH535 GDSC1 0.1250 32.0000
K2[HUMANMELANOMA] FMK GDSC1 0.0781 20.0000
K2[HUMANMELANOMA] Foretinib GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] FR-180204 GDSC1 0.0781 20.0000
K2[HUMANMELANOMA] FS106 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] FS112 GDSC1 0.0195 5.0000
K2[HUMANMELANOMA] FTI-277 GDSC1 0.0040 1.0240
K2[HUMANMELANOMA] Fulvestrant GDSC1,GDSC2 0.0010 10.0000
K2[HUMANMELANOMA] FY012 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] FY026 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] FY069 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] GDC0810 GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Gefitinib GDSC1,GDSC2 0.0020 2.0000
K2[HUMANMELANOMA] Gemcitabine GDSC1,GDSC2 0.0002 10.0000
K2[HUMANMELANOMA] Genentech Cpd 10 GDSC1 0.0400 10.2400
K2[HUMANMELANOMA] GNE-317 GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] GSK-J4 GDSC1 0.1172 30.0000
K2[HUMANMELANOMA] GSK1070916 GDSC1 0.0100 2.5600
K2[HUMANMELANOMA] GSK1904529A GDSC1,GDSC2 0.0040 5.0000
K2[HUMANMELANOMA] GSK2578215A GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] GSK2606414 GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] GSK269962A GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] GSK343 GDSC2 0.0010 1.0000
K2[HUMANMELANOMA] GSK429286A GDSC1 0.0781 20.0000
K2[HUMANMELANOMA] GSK591 GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] GSK650394 GDSC1 0.0625 16.0000
K2[HUMANMELANOMA] GSK690693 GDSC1 0.0400 10.2400
K2[HUMANMELANOMA] GW-2580 GDSC1 0.0781 20.0000
K2[HUMANMELANOMA] GW441756 GDSC1,GDSC2 0.0020 2.0000
K2[HUMANMELANOMA] HG-5-113-01 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] HG-5-88-01 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] HG6-64-1 GDSC1 0.0200 5.1200
K2[HUMANMELANOMA] I-BET-762 GDSC1,GDSC2 0.0100 20.0000
K2[HUMANMELANOMA] I-BET151 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] I-BRD9 GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] I-CBP112 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] IAP_5620 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] IAP_7638 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] Ibrutinib GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] ICL1100013 GDSC1 0.0781 20.0000
K2[HUMANMELANOMA] Idelalisib GDSC1 0.0781 20.0000
K2[HUMANMELANOMA] IGFR_3801 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] IOX2 GDSC1,GDSC2 0.0004 0.5000
K2[HUMANMELANOMA] IPA-3 GDSC1 0.1250 32.0000
K2[HUMANMELANOMA] Ipatasertib GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Irinotecan GDSC2 0.0050 5.0000
K2[HUMANMELANOMA] Ispinesib Mesylate GDSC1 0.0005 0.1280
K2[HUMANMELANOMA] IWP-2 GDSC2 0.0010 1.0000
K2[HUMANMELANOMA] JAK1_3715 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] JAK3_7406 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] JNK Inhibitor VIII GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] JNK-9L GDSC1 0.0200 5.1200
K2[HUMANMELANOMA] JQ1 GDSC1,GDSC2 0.0039 10.0000
K2[HUMANMELANOMA] JQ12 GDSC1 0.0200 5.1200
K2[HUMANMELANOMA] JW-7-24-1 GDSC1 0.0400 10.2400
K2[HUMANMELANOMA] KIN001-236 GDSC1 0.0400 10.2400
K2[HUMANMELANOMA] KIN001-244 GDSC1 0.0781 20.0000
K2[HUMANMELANOMA] KIN001-260 GDSC1 0.0781 20.0000
K2[HUMANMELANOMA] KIN001-266 GDSC1 0.0781 20.0000
K2[HUMANMELANOMA] KIN001-270 GDSC1 0.0781 20.0000
K2[HUMANMELANOMA] KRAS (G12C) Inhibitor-12 GDSC2 0.0200 20.0000
K2[HUMANMELANOMA] KU-55933 GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] KU-60019 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] Lapatinib GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] LCL161 GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Leflunomide GDSC2 0.1001 100.0000
K2[HUMANMELANOMA] Lenalidomide GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Lestaurtinib GDSC1,GDSC2 0.0020 2.0000
K2[HUMANMELANOMA] LFM-A13 GDSC1 0.0625 16.0000
K2[HUMANMELANOMA] LGK974 GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Linifanib GDSC1 0.0040 1.0240
K2[HUMANMELANOMA] Linsitinib GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] LJI308 GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Luminespib GDSC1,GDSC2 0.0003 0.2560
K2[HUMANMELANOMA] LY2109761 GDSC2 0.0050 5.0000
K2[HUMANMELANOMA] Masitinib GDSC1 0.0781 20.0000
K2[HUMANMELANOMA] MCT1_6447 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] MCT4_1422 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] Methotrexate GDSC1,GDSC2 0.0008 1.0000
K2[HUMANMELANOMA] MG-132 GDSC2 0.0040 4.0000
K2[HUMANMELANOMA] Midostaurin GDSC1 0.0020 0.5120
K2[HUMANMELANOMA] MIRA-1 GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Mirin GDSC1,GDSC2 0.1001 100.0000
K2[HUMANMELANOMA] Mitomycin-C GDSC1 0.0625 16.0000
K2[HUMANMELANOMA] MK-1775 GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] MK-2206 GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] MK-8776 GDSC2 0.0050 5.0000
K2[HUMANMELANOMA] ML323 GDSC2 0.0200 20.0000
K2[HUMANMELANOMA] MN-64 GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Motesanib GDSC1,GDSC2 0.0078 10.0000
K2[HUMANMELANOMA] MPS-1-IN-1 GDSC1 0.0781 20.0000
K2[HUMANMELANOMA] N22899-6-C1 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] N23918-95-7 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] N24798-49-A1 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] Navitoclax GDSC1,GDSC2 0.0020 2.0000
K2[HUMANMELANOMA] NG-25 GDSC1 0.0400 10.2400
K2[HUMANMELANOMA] Nilotinib GDSC1,GDSC2 0.0078 10.0000
K2[HUMANMELANOMA] Niraparib GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] NPK76-II-72-1 GDSC1 0.0400 10.2400
K2[HUMANMELANOMA] NSC-207895 GDSC1 0.0781 20.0000
K2[HUMANMELANOMA] NSC-87877 GDSC1 0.0625 16.0000
K2[HUMANMELANOMA] NU7441 GDSC1,GDSC2 0.0078 10.0000
K2[HUMANMELANOMA] Nutlin-3a GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] NVP-ADW742 GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] NVP-BHG712 GDSC1 0.0400 10.2400
K2[HUMANMELANOMA] Obatoclax Mesylate GDSC1 0.0625 16.0000
K2[HUMANMELANOMA] OF-1 GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Olaparib GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Omipalisib GDSC1 0.0005 0.1280
K2[HUMANMELANOMA] OSI-027 GDSC1,GDSC2 0.0100 20.0000
K2[HUMANMELANOMA] OSI-930 GDSC1 0.0400 10.2400
K2[HUMANMELANOMA] Osimertinib GDSC2 0.0010 1.0000
K2[HUMANMELANOMA] OSU-03012 GDSC1 0.0625 16.0000
K2[HUMANMELANOMA] OTX015 GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Oxaliplatin GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] P22077 GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] PAC-1 GDSC1 0.0100 2.5600
K2[HUMANMELANOMA] Paclitaxel GDSC2 0.0001 0.1000
K2[HUMANMELANOMA] Palbociclib GDSC1,GDSC2 0.0040 4.0000
K2[HUMANMELANOMA] PARP_0108 GDSC1 0.0098 2.5000
K2[HUMANMELANOMA] PARP_9482 GDSC1 0.0098 2.5000
K2[HUMANMELANOMA] PARP_9495 GDSC1 0.0098 2.5000
K2[HUMANMELANOMA] Pazopanib GDSC1 0.0312 8.0000
K2[HUMANMELANOMA] PCI-34051 GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] PD0325901 GDSC1,GDSC2 0.0010 2.5000
K2[HUMANMELANOMA] PD173074 GDSC1,GDSC2 0.0078 10.0000
K2[HUMANMELANOMA] Pelitinib GDSC1 0.0098 2.5000
K2[HUMANMELANOMA] Pevonedistat GDSC1,GDSC2 0.0039 10.0000
K2[HUMANMELANOMA] PF-4708671 GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] PF-562271 GDSC1 0.0100 2.5600
K2[HUMANMELANOMA] PFI-1 GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] PFI3 GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] PHA-793887 GDSC1 0.0400 10.2400
K2[HUMANMELANOMA] Phenformin GDSC1 15.6250 4000.0000
K2[HUMANMELANOMA] PI-103 GDSC1 0.0400 10.2400
K2[HUMANMELANOMA] PI3Ka_4409 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] Picolinici-acid GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Pictilisib GDSC1,GDSC2 0.0040 4.0000
K2[HUMANMELANOMA] PIK-93 GDSC1 0.0781 20.0000
K2[HUMANMELANOMA] Piperlongumine GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] PLK_6522 GDSC1 0.0024 0.6250
K2[HUMANMELANOMA] PLX-4720 GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Ponatinib GDSC1 0.0020 0.5120
K2[HUMANMELANOMA] PRIMA-1MET GDSC2 0.0300 30.0000
K2[HUMANMELANOMA] PRT062607 GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Pyridostatin GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] QL-VIII-58 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] QL-X-138 GDSC1 0.0400 10.2400
K2[HUMANMELANOMA] QL-XI-92 GDSC1 0.0400 10.2400
K2[HUMANMELANOMA] QL-XII-47 GDSC1 0.0400 10.2400
K2[HUMANMELANOMA] QL-XII-61 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] QS11 GDSC1 0.0400 10.2400
K2[HUMANMELANOMA] Quizartinib GDSC1 0.0040 1.0240
K2[HUMANMELANOMA] RAF_9304 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] Rapamycin GDSC2 0.0001 0.1000
K2[HUMANMELANOMA] Refametinib GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Ribociclib GDSC2 0.0020 2.0000
K2[HUMANMELANOMA] RO-3306 GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] rTRAIL GDSC1 0.0004 0.1000
K2[HUMANMELANOMA] Rucaparib GDSC1,GDSC2 0.0050 5.0000
K2[HUMANMELANOMA] Ruxolitinib GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] RVX-208 GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Sabutoclax GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Sapitinib GDSC2 0.0050 5.0000
K2[HUMANMELANOMA] Savolitinib GDSC2 0.0010 1.0000
K2[HUMANMELANOMA] SB216763 GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] SB505124 GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] SB52334 GDSC1 0.0781 20.0000
K2[HUMANMELANOMA] SB590885 GDSC1,GDSC2 0.0050 5.0000
K2[HUMANMELANOMA] SCH772984 GDSC2 0.0050 5.0000
K2[HUMANMELANOMA] Selisistat GDSC1 0.0781 20.0000
K2[HUMANMELANOMA] Selumetinib GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Sepantronium bromide GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Serdemetan GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] SGC0946 GDSC1,GDSC2 0.0005 0.5000
K2[HUMANMELANOMA] Shikonin GDSC1 0.0625 16.0000
K2[HUMANMELANOMA] SL0101 GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] SN-38 GDSC1,GDSC2 0.0002 10.0000
K2[HUMANMELANOMA] SNX-2112 GDSC1 0.0100 2.5600
K2[HUMANMELANOMA] Sorafenib GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Staurosporine GDSC2 0.0078 2.0000
K2[HUMANMELANOMA] STF-62247 GDSC1 0.0400 10.2400
K2[HUMANMELANOMA] T0901317 GDSC1 0.0400 10.2400
K2[HUMANMELANOMA] TAK-715 GDSC1 0.0781 20.0000
K2[HUMANMELANOMA] Talazoparib GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Tamoxifen GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Tanespimycin GDSC1,GDSC2 0.0010 1.0000
K2[HUMANMELANOMA] TANK_1366 GDSC1 0.0098 2.5000
K2[HUMANMELANOMA] Taselisib GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Telomerase Inhibitor IX GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Temozolomide GDSC1,GDSC2 0.0300 30.0000
K2[HUMANMELANOMA] Temsirolimus GDSC1,GDSC2 0.0008 1.0000
K2[HUMANMELANOMA] Thapsigargin GDSC1 0.0020 0.5120
K2[HUMANMELANOMA] THZ-2-102-1 GDSC1 0.0098 2.5000
K2[HUMANMELANOMA] THZ-2-49 GDSC1 0.0781 20.0000
K2[HUMANMELANOMA] Tipifarnib GDSC1 0.0625 16.0000
K2[HUMANMELANOMA] Tivozanib GDSC1 0.0005 0.1280
K2[HUMANMELANOMA] TL-1-85 GDSC1 0.0400 10.2400
K2[HUMANMELANOMA] TL-2-105 GDSC1 0.0400 10.2400
K2[HUMANMELANOMA] Tozasertib GDSC2 0.0050 5.0000
K2[HUMANMELANOMA] TPCA-1 GDSC1 0.0781 20.0000
K2[HUMANMELANOMA] Trametinib GDSC1,GDSC2 0.0010 1.0000
K2[HUMANMELANOMA] Tretinoin GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] TTK_3146 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] Tubastatin A GDSC1 0.0781 20.0000
K2[HUMANMELANOMA] TW 37 GDSC1 0.0195 5.0000
K2[HUMANMELANOMA] Ulixertinib GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] UNC0638 GDSC1 0.0781 40.0000
K2[HUMANMELANOMA] UNC0642 GDSC1 0.0020 0.5000
K2[HUMANMELANOMA] UNC1215 GDSC1 0.0039 1.0000
K2[HUMANMELANOMA] Uprosertib GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] VE-822 GDSC2 0.0050 5.0000
K2[HUMANMELANOMA] VE821 GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Veliparib GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Venetoclax GDSC2 0.0010 1.0000
K2[HUMANMELANOMA] Vinblastine GDSC1 0.0004 0.1000
K2[HUMANMELANOMA] Vinorelbine GDSC1,GDSC2 0.0001 0.1000
K2[HUMANMELANOMA] Vismodegib GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] VNLG-124 GDSC1 0.0200 5.1200
K2[HUMANMELANOMA] Vorinostat GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] VX-11e GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] VX-702 GDSC1 0.0078 2.0000
K2[HUMANMELANOMA] Wee1 Inhibitor GDSC1,GDSC2 0.0078 10.0000
K2[HUMANMELANOMA] WEHI-539 GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] WHI-P97 GDSC1 0.0400 10.2400
K2[HUMANMELANOMA] WIKI4 GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] Wnt-C59 GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] WZ3105 GDSC1 0.0050 1.2800
K2[HUMANMELANOMA] WZ4003 GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] XAV939 GDSC1,GDSC2 0.0050 5.0000
K2[HUMANMELANOMA] XMD11-85h GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] XMD13-2 GDSC1 0.0400 10.2400
K2[HUMANMELANOMA] XMD14-99 GDSC1 0.0400 10.2400
K2[HUMANMELANOMA] XMD15-27 GDSC1 0.0400 10.2400
K2[HUMANMELANOMA] XMD8-92 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] Y-39983 GDSC1 0.0781 20.0000
K2[HUMANMELANOMA] YK-4-279 GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] YM201636 GDSC1 0.0200 5.1200
K2[HUMANMELANOMA] ZG-10 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] Zibotentan GDSC1 0.0781 20.0000
K2[HUMANMELANOMA] ZL049 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] ZL109 GDSC1 0.0391 10.0000
K2[HUMANMELANOMA] ZM447439 GDSC1,GDSC2 0.0100 10.0000
K2[HUMANMELANOMA] ZSTK474 GDSC1 0.0200 5.1200

IC50

IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.

Drugs with highest and lowest IC50

IC90

IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.

Drugs with highest and lowest IC90

AUC

AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.

Drugs with highest and lowest AUC